Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001350071-13-000024
Filing Date
2013-02-13
Accepted
2013-02-13 13:31:17
Documents
10
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 aenzbdecq.htm 10-Q 162740
2 SECTION 302 CERTIFICATION ex311sec302.htm EX-31.1 10125
3 SECTION 302 CERTIFICATION ex312sec302.htm EX-31.2 10147
4 SECTION 906 CERTIFICATION ex321sec906.htm EX-32.1 3879
5 SECTION 906 CERTIFICATION ex322sec906.htm EX-32.2 3881
  Complete submission text file 0001350071-13-000024.txt   710372

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enzb-20121231.xml EX-101.INS 36812
7 XBRL SCHEMA FILE enzb-20121231.xsd EX-101.SCH 8697
8 XBRL CALCULATION FILE enzb-20121231_cal.xml EX-101.CAL 7557
9 XBRL LABEL FILE enzb-20121231_lab.xml EX-101.LAB 56777
10 XBRL PRESENTATION FILE enzb-20121231_pre.xml EX-101.PRE 39496
Mailing Address 16773 W. PARK DR. CHAGRIN FALLS OH 44023
Business Address 16773 W. PARK DR. CHAGRIN FALLS OH 44023 440-708-0012
EnzymeBioSystems (Filer) CIK: 0001471968 (see all company filings)

EIN.: 270464302 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-53854 | Film No.: 13601676
SIC: 2834 Pharmaceutical Preparations